Opella

Opella is a global consumer healthcare company based in France, focusing on over-the-counter (OTC) medicines, vitamins, minerals, and supplements. With a mission to simplify self-care for over half a billion consumers, Opella is the third-largest player in the €190 billion OTC and VMS market. The company employs over 11,000 people across more than 100 countries and operates 13 manufacturing sites and 4 science and innovation centers. Opella's product portfolio includes well-known brands in categories such as allergy relief, digestive health, pain relief, skincare, and dietary supplements. Notable brands include Allegra, Dulcolax, and Doliprane, along with North America-specific products like Xyzal and Icy Hot. The company emphasizes science-based innovation and sustainability, holding B Corp certification in multiple markets. With a strong presence in North America, Europe, and Latin America, Opella distributes its products through major retailers, ensuring broad access to its trusted brands.